Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

Share Price is delayed by 15 minutes
Get Live Data
701.00    0.00 (0.00%)
Bid:
692.00
Ask:
710.00
Spread: 18.00 (2.601%)
Market Cap: £247.03m
BPM Live PriceLast checked at - London Stock Exchange

Intraday B.p Marsh Share Chart

Special Dividend Declaration

15 Dec 2025 07:00

RNS Number : 4725L
B.P. Marsh & Partners PLC
15 December 2025
 

15 December 2025

 

B.P. Marsh & Partners Plc

("B.P. Marsh", "the Company" or "the Group")

Special Dividend Declaration

 

Further to the announcement made on 28th October 2025, B.P. Marsh & Partners Plc (AIM: BPM), the specialist private equity investor in early-stage financial services businesses, is pleased to confirm that it has received consideration of £27.6m from the disposal of its shareholding in Stewart Specialty Risk Underwriting Ltd (the "Proceeds").

 

Use of Proceeds

 

Following receipt of the Proceeds, the Company is pleased to confirm its intention to declare a Special Dividend of £8.0m, equating to 22.33p per share.

 

The Special Dividend of circa 22.33p per share will be payable on Friday 27th March 2026 to Shareholders on the Register as at Friday 6th March 2026. The associated ex-dividend date will be Thursday 5th March 2026.

 

In addition to the Special Dividend of £8.0m, and as previously guided, the Company's intention is to pay a dividend of at least £5.0m per annum in each of the financial years ending 31st January 2027 and 31st January 2028, subject always to the Board's right to recommend an increased or decreased Final Dividend, for example in the event of significant realisations or capital commitments.

 

The Board periodically reviews its capital allocation policy, including the frequency of dividend payments for subsequent years.

 

This announcement contains inside information. The person responsible for arranging the release of this announcement on behalf of the Company is Ruth Pearson.

 

For further information on B.P. Marsh, its strategy and current portfolio, please visit www.bpmarsh.co.uk or contact:

 

 

B.P. Marsh & Partners Plc

Daniel Topping / Alice Foulk

 

Tel: +44 (0) 20 7233 3112

 

Nominated Adviser & Joint Corporate Broker:

 

Singer Capital Markets Advisory LLP

Tel: +44 (0) 20 7496 3000

Charles Leigh-Pemberton / Asha Chotai / James Todd

 

Joint Corporate Broker:

Investec Bank plc

Christopher Baird / David Anderson / Maria Gomez de Olea

 

Tel: +44 (0) 20 7597 5970

Financial PR & Investor Relations:

Tavistock

Simon Hudson / Katie Hopkins / Kuba Stawiski

 

Tel: +44 (0) 20 7920 3150

bpmarsh@tavistock.co.uk

 

 

-Ends-

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVGPGBUPUPAURW
Date   Source Headline
24th Feb 20257:00 amRNSTrading Statement
14th Feb 20252:58 pmRNSHolding(s) in Company
23rd Jan 20257:00 amRNSInterim Dividend Declaration
8th Jan 202510:20 amRNSDirector/PDMR Shareholding
6th Jan 202512:00 pmRNSDirector/PDMR Shareholding
12th Dec 20243:18 pmRNSDirector/PDMR Shareholding
27th Nov 20247:00 amRNSFollow on Investment – XPT Group LLC
12th Nov 20249:36 amRNSDirector/PDMR Shareholding
31st Oct 20245:45 pmRNSCancellation of Shares & Buy-Back Programme Update
30th Oct 20247:00 amRNSNew Investment – SRT & Partners Limited
29th Oct 202412:40 pmRNSFollow on Investment – Pantheon Specialty Group
29th Oct 20249:40 amRNSSale of Lilley Plummer Holdings Limited
23rd Oct 20247:00 amRNSHalf Year Results
14th Oct 20247:00 amRNSNew Investment – Volt UW HoldCo Ltd
11th Oct 202410:10 amRNSTransaction in Own Shares
9th Oct 202410:00 amRNSNotice of HY Results and Investor Presentation
7th Oct 20244:03 pmRNSTransaction in Own Shares
1st Oct 20243:37 pmRNSTransaction in Own Shares
1st Oct 202411:04 amRNSTransaction in Own Shares
30th Sep 20242:20 pmRNSNew Investment – CEE Specialty s.r.o.
30th Sep 20249:00 amRNSTransaction in Own Shares
27th Sep 20241:10 pmRNSTransaction in Own Shares
26th Sep 20247:00 amRNSTransaction in Own Shares
23rd Sep 202412:05 pmRNSTransaction in Own Shares
19th Sep 20245:02 pmRNSTransaction in Own Shares
18th Sep 20243:15 pmRNSTransaction in Own Shares
18th Sep 20243:00 pmRNSDirector/PDMR Shareholding
17th Sep 20245:00 pmRNSTransaction in Own Shares
17th Sep 20247:02 amRNSTransaction in Own Shares
17th Sep 20247:01 amRNSAppointment of Joint Corporate Broker
17th Sep 20247:00 amRNSTrading Statement
16th Sep 20242:15 pmRNSDirectorate Change
13th Sep 20243:04 pmRNSTransaction in Own Shares
10th Sep 20241:43 pmRNSTransaction in Own Shares
5th Sep 20242:00 pmRNSDirectorate Change
5th Sep 20247:00 amRNSTransaction in Own Shares
2nd Sep 20245:05 pmRNSTransaction in Own Shares
2nd Sep 202410:09 amRNSTransaction in Own Shares
27th Aug 20243:15 pmRNSTransaction in Own Shares
13th Aug 20249:33 amRNSTransaction in Own Shares
6th Aug 20244:25 pmRNSTransaction in Own Shares
5th Aug 20242:03 pmRNSTransaction in Own Shares
5th Aug 20249:20 amRNSDirector/PDMR Shareholding
2nd Aug 20248:45 amRNSShare Buy-Back Programme Update
23rd Jul 20242:35 pmRNSResult of AGM
19th Jul 20242:32 pmRNSTransaction in Own Shares
18th Jul 202411:19 amRNSTransaction in Own Shares
16th Jul 20243:20 pmRNSTransaction in Own Shares
12th Jul 20248:35 amRNSTransaction in Own Shares
10th Jul 20242:48 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.